🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/03/1988 | 8,37 | 8,38 | 8,24 | 8,32 | -0,79% | 1,58% | 9.252.792 |
| 15/03/1988 | 8,42 | 8,44 | 8,36 | 8,39 | -0,47% | 1,02% | 4.998.960 |
| 14/03/1988 | 8,49 | 8,50 | 8,38 | 8,43 | -0,62% | 1,40% | 5.387.558 |
| 11/03/1988 | 8,54 | 8,58 | 8,31 | 8,48 | -0,39% | 3,18% | 8.877.398 |
| 10/03/1988 | 8,71 | 8,71 | 8,51 | 8,51 | -2,21% | 2,28% | 6.396.782 |
| 09/03/1988 | 8,69 | 8,73 | 8,68 | 8,71 | +0,00% | 0,61% | 7.432.416 |
| 08/03/1988 | 8,69 | 8,73 | 8,65 | 8,71 | +0,46% | 0,92% | 6.472.238 |
| 07/03/1988 | 8,69 | 8,72 | 8,60 | 8,67 | -0,15% | 1,37% | 5.861.045 |
| 04/03/1988 | 8,67 | 8,71 | 8,60 | 8,68 | +0,00% | 1,30% | 6.681.629 |
| 03/03/1988 | 8,71 | 8,74 | 8,65 | 8,68 | -0,30% | 1,07% | 4.531.133 |
| 02/03/1988 | 8,79 | 8,83 | 8,69 | 8,71 | -0,61% | 1,51% | 5.332.853 |
| 01/03/1988 | 8,77 | 8,79 | 8,72 | 8,76 | -0,08% | 0,76% | 7.215.480 |
| 29/02/1988 | 8,57 | 8,77 | 8,57 | 8,77 | +2,24% | 2,32% | 8.011.541 |
| 26/02/1988 | 8,59 | 8,61 | 8,55 | 8,57 | -0,15% | 0,69% | 4.534.906 |
| 25/02/1988 | 8,67 | 8,79 | 8,55 | 8,59 | -0,76% | 2,75% | 10.716.638 |
| 24/02/1988 | 8,73 | 8,76 | 8,60 | 8,65 | -1,29% | 1,82% | 8.669.894 |
| 23/02/1988 | 8,64 | 8,81 | 8,60 | 8,77 | +1,77% | 2,45% | 11.271.240 |
| 22/02/1988 | 8,55 | 8,61 | 8,51 | 8,61 | +0,78% | 1,24% | 8.545.392 |
| 19/02/1988 | 8,41 | 8,55 | 8,36 | 8,55 | +1,57% | 2,28% | 7.749.331 |
| 18/02/1988 | 8,41 | 8,45 | 8,35 | 8,42 | -0,39% | 1,18% | 4.978.210 |
| 17/02/1988 | 8,46 | 8,53 | 8,40 | 8,45 | +0,08% | 1,57% | 8.062.474 |
| 16/02/1988 | 8,38 | 8,44 | 8,34 | 8,44 | +0,79% | 1,27% | 5.031.029 |
| 12/02/1988 | 8,32 | 8,42 | 8,32 | 8,38 | +0,80% | 1,19% | 5.378.126 |
| 11/02/1988 | 8,38 | 8,53 | 8,24 | 8,31 | -0,79% | 3,48% | 10.752.480 |
| 10/02/1988 | 8,11 | 8,38 | 8,10 | 8,38 | +3,10% | 3,35% | 13.095.389 |
| 09/02/1988 | 8,07 | 8,12 | 8,03 | 8,12 | +1,15% | 1,15% | 5.521.493 |
| 08/02/1988 | 8,00 | 8,08 | 7,95 | 8,03 | -0,08% | 1,66% | 5.415.854 |
| 05/02/1988 | 8,02 | 8,10 | 8,00 | 8,04 | +0,66% | 1,24% | 8.671.781 |
| 04/02/1988 | 7,96 | 8,04 | 7,93 | 7,98 | +0,58% | 1,50% | 9.192.427 |
| 03/02/1988 | 8,15 | 8,18 | 7,90 | 7,94 | -3,00% | 3,42% | 7.253.208 |